/
Other
Adolescent
30
Pipeline Programs↗
36
Active Trials↗
59
Companies Involved↗
Adolescent is an emerging landscape with 30 programs across 59 companies. The most active players are Gilead, KalVista Pharmaceuticals, Ltd., Vanda Pharmaceuticals. 10 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical6
Phase 13
Phase 211
Phase 310
Approved
No programs
Analysis
Modality Breakdown
96%
Small molecule
26 of 27 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 27 classified programs, each share of the total. Modality classified for 100% of 30 pipeline programs.
Analysis
Trial Status
292
clinical trials
Completed208 · 71%
Recruiting23 · 8%
Unknown status16 · 5%
Terminated16 · 5%
Withdrawn15 · 5%
Active, not recruiting9 · 3%
Other5 · 2%
Clinical Trials
Trial Activity
292 trials
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
Recruiting·AAustralian & New Zealand Children's Haematology/Oncology Group·Phase 1/2·NCT06208657·90 enrolled
Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)
Recruiting·FFirst Affiliated Hospital of Chongqing Medical University·Phase 1/2·NCT05814640·520 enrolled
Page 1 of 20
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)